On-Demand Panel: The Need for Speed in CGT Manufacturing
Cell & Gene Day 2023
Increasing Throughput and Efficiency Through Process Innovation, Automation, and Digitization
Manufacturing is one of the biggest obstacles for cell and gene therapy companies, requiring significant investment and highly specialized processes that can be very complex and difficult to develop and maintain in-house. With the paradigm shift from ‘Make’ to ‘Buy’ for advanced therapy manufacturing, innovator companies need to carefully consider their choice in CDMO partner for their manufacturing needs to ensure adequate, on-time capacity for the patients who desperately need these life changing therapies.
This panel will explore:
- – Paradigm shift from ‘Make’ to ‘Buy’ for CGT manufacturing
- – Strategies to increase throughput with innovations in processes (automation, closed systems etc.) and suite design
- – Impact of digitization for process monitoring, batch records and predictive analytics
- – Supply chain optimization to reduce costs and improve efficiency
View the full panel discussion below.
About The Center for Breakthrough Medicines (CBM)
Center for Breakthrough Medicines (CBM) is a purpose-built and patient-driven, cell and gene therapy contract development and manufacturing organization (CDMO) uniquely positioned to enable pharma and biotech companies to develop, test, and manufacture life-saving therapies on a global scale. Ideally located in the heart of Philadelphia’s Cellicon Valley, CBM has assembled the most accomplished cell and gene therapy experts in the world, armed with cutting-edge and innovative technologies, to offer scalable, end-to-end, best-in-class services from pre-clinical through commercial, including process development, plasmid DNA, vector manufacturing, cell banking, cell processing, and a full suite of complementary and standalone testing and analytical capabilities.